StockStory.org on MSN
Exponent (NASDAQ:EXPO) beats expectations in strong Q1 CY2026
Scientific consulting firm Exponent (NASDAQ:EXPO) announced in Q1 CY2026, with sales up 21% year on year to $166.3 million.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results